日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.

LATS1 和 LATS2 的缺失通过增强 AKT 活性和 PD-L1 表达促进卵巢肿瘤的形成

Zhu Yalun, Abedini Atefeh, Rodriguez Galaxia M, McCloskey Curtis W, Abou-Hamad John, Salah Omar Salah, Larocque Janie, Tsoi Mayra F, Boerboom Derek, Cook David, Vanderhyden Barbara

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

转谷氨酰胺酶 2 通过调节免疫微环境来调控卵巢癌转移

Ibrahim Dalia, Grondin Melanie, Galpin Kristianne, Asif Sara, Thompson Emily, Nersesian Sarah, Abou-Hamad John, Echaibi Maryam, Rodriguez Galaxia M, Navals Pauline, Macdonald Elizabeth, Ryan Brianna, Cook David P, Keillor Jeffrey W, Vanderhyden Barbara C

Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer

特定基因突变影响卵巢癌中溶瘤病毒的化疗耐药性和治疗效果

Cudmore, Alison O; Rodriguez, Galaxia M; Maranda, Vincent; Farokhi Boroujeni, Salar; Murshed, Humaira; Macdonald, Elizabeth A; Grondin, Melanie; Garson, Kenneth; Matuszewska, Kathy; Diallo, Jean-Simon; Petrik, James J; Vanderhyden, Barbara C

Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential

传统DNA损伤癌症疗法与新兴的cGAS-STING激活:免疫治疗潜力的回顾与展望

Lewicky, Jordan D; Martel, Alexandrine L; Gupta, Mukul Raj; Roy, René; Rodriguez, Galaxia M; Vanderhyden, Barbara C; Le, Hoang-Thanh

Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success

揭示卵巢肿瘤的免疫原性是治疗成功的关键催化剂

Rodriguez, Galaxia M; Yakubovich, Edward; Vanderhyden, Barbara C

Mesenchymal ovarian cancer cells promote CD8(+) T cell exhaustion through the LGALS3-LAG3 axis.

间质性卵巢癌细胞通过 LGALS3-LAG3 轴促进 CD8(+) T 细胞耗竭

Yakubovich Edward, Cook David P, Rodriguez Galaxia M, Vanderhyden Barbara C

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.

小鼠卵巢癌模型的肿瘤免疫特征:卵巢癌免疫治疗研究的重要工具

Rodriguez Galaxia M, Galpin Kristianne J C, Cook David P, Yakubovich Edward, Maranda Vincent, Macdonald Elizabeth A, Wilson-Sanchez Juliette, Thomas Anjali L, Burdette Joanna E, Vanderhyden Barbara C

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy

上皮性卵巢癌的肿瘤微环境及其对免疫治疗反应的影响

Rodriguez, Galaxia M; Galpin, Kristianne J C; McCloskey, Curtis W; Vanderhyden, Barbara C

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics

卵巢癌免疫疗法:临床前模型和新兴疗法

McCloskey, Curtis W; Rodriguez, Galaxia M; Galpin, Kristianne J C; Vanderhyden, Barbara C

NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes

NLRC5 通过增强肿瘤抗原的加工和呈递给 CD8(+) T 淋巴细胞来诱导抗肿瘤免疫。

Rodriguez, Galaxia M; Bobbala, Diwakar; Serrano, Daniel; Mayhue, Marian; Champagne, Audrey; Saucier, Caroline; Steimle, Viktor; Kufer, Thomas A; Menendez, Alfredo; Ramanathan, Sheela; Ilangumaran, Subburaj